Swish Club Rebrands To SwishX, Pivots To AI For Pharma
3 Articles
3 Articles
SwishX launches Agentic AI platform for pharma and Medtech firms
SwishX has launched an AI platform designed for pharmaceutical and medtech companies, focusing on sales, marketing, distribution and business operations. The Bengaluru-based startup said the platform uses ‘Agentic AI’ technology to automate workflows and analyse large volumes of business and market data. SwishX also announced that it has raised $2.2 million in seed funding from investors including Powerhouse Ventures, Blume Ventures, Sadev Ventu…
Ex-Google, Amazon Execs-Founded SwishX Launches World’s Ist Agentic AI Platform for Pharma & Medtech
Bengaluru-based startup seed-funded for $2.2 million backed by Powerhouse Ventures, Blume Ventures, Sadev Ventures, Atrium Ventures, and othersTargets $5M ARR and 100+ enterprise clientsPlans expansion across emerging markets including Latin America, Southeast Asia, Middle East, Africa, and Eastern EuropeSwishX today announced its launch, introducing the World’s first Agentic AI platform built exclusively for pharmaceutical and medtech companies…
Swish Club Rebrands To SwishX, Pivots To AI For Pharma
After about three years of operating as an IT asset management platform and raising $4.5 Mn, Swish Club has rebranded itself as SwishX. Alongside, the startup has also pivoted to become an agentic AI platform for pharmaceutical and medtech companies. In its new avatar, SwishX will offer agentic AI tools to help pharma companies streamline operations across key business areas, including sales, marketing, distribution, and business growth. Speakin…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
